Benzene-Induced Hematotoxicity and Myelotoxicity by Short-Term Repeated Oral Administration in Mice

다국어 초록 (Multilingual Abstract)

Exposure dose of benzene has been postulated to be critical to induce hemopoietic malignancies. By long-term inhalation of benzene, 300 ppm has been shown to be the dose that induces high frequency of leukemia with the least animal mortality in the mouse. With regard to the benzene studies, determination of the oral dose that will be corresponding to the critical inhalation dose could be important to design the experimental protocol based on oral administration. Based on the background data such as the respiratory volume, absorption factor, and so on, we, therefore, calculated a potential oral dose that is expected to be corresponding to 300 ppm of inhalation dose. The determined oral dose was 150 ㎎/㎏ B.W. We then evaluated, using C57BL/6 mice, the toxic effects of benzene on the peripheral blood and the bone marrow (BM) by oral administration of the selected dose once a day for 1 and 2 weeks. Leukocyte, red blood cell number and BM cellularity were respectively decreased to 47.8%, 72.3% and 66.7% of the respective control level by 1-week oral administration of benzene, and to 30.8%, 60.2% and 80.2% by 2-week oral administration. Changes in the leukocyte numbers were mainly due to the marked decrease of lymphocytes. According to the results, the changes of the parameters examined were generally corresponding to the change levels by the 2-week inhalation. In conclusion, the selected dose, 150 ㎎/㎏ B.W., was a reliable dose corresponding to the 300 ppm benzene inhalation, which was verified by in vivo mouse study.

목차 (Table of Contents)

• 재료 및 방법
• 결과
• 고찰
• 감사의 글
• 참고문헌

참고문헌 (Reference)

1 Snyder, C.A, "Toxicity of chronic benzene inhalation: CD-1 mice exposed to 300 ppm" 29 (29): 385-391, 1982

2 Yardley-Jones, A, "The toxicity of benzene and its metabolism and molecular pathology in human risk assessment" 48 : 437-444, 1991

3 Ross, D, "The role of metabolism and specific metabolites in benzene-induced toxicity: evidence and issues" A61 : 367-372, 2000

4 Gut, I, "The role of CYP2E1 and 2B1 in metabolic activation of benzene derivatives" 71 : 45-56, 1996

5 Snyder, C.A, "The inhalation toxicology of benzene: Incidence of hematopoietic neoplasms and hematotoxicity in AKR/J and C57BL/6J mice" 54 : 323-331, 1980

6 Weaver, C.V, "The effects of benzene exposure on apoptosis in epithelial lung cells: localization by terminal deoxynucleotidyl transferasemediated dUTP-biotin nick end labeling (TUNEL) and the immunocytochemical localization of apoptosis-related gene products" localization by terminal deoxynucleotidyl transferasemediated dUTP-biotin nick end labeling(TUNEL)and the immunocytochemical localization of apoptosis-related gene products.Cell Biol.Toxicol.23,201-220. 23 : 201-220, 2007

7 Laskin, D.L, "Role of nitric oxide in hematosuppression and benzeneinduced toxicity. Environ" 104 : 1283-1287, 1996

8 Valentine, J.L, "Reduction of benzene metabolism and toxicity in mice that lack CYP2E1 expression" 141 : 205-213, 1996

9 Dean, B.J, "Recent findings on the genetic toxicology of benzene, toluene, xylenes and phenols" 154 : 153-181, 1985

10 Subrahmanyam,V.V, "Potential role of free radicals in benzene-induced myelotoxicity and leukemia" 11 : 495-515, 1991

11 Subrahmanyam,V.V, "Phenol-induced stimulation of hydroquinone bioactivation in mouse bone marrow in vivo: possible implications in benzene myelotoxicity" 62 : 107-116, 1990

12 Yoon, B.I, "Mechanism of action of benzene toxicity: Cell cycle suppression in hemopoietic progenitor cells (CFU-GM)" 29 : 278-285, 2001

13 Yoon, B.I, "Mechanism of Benzene- Induced Hematotoxicity and Leukemogenicity: cDNA Microarry Analyses Using Mouse Bone Marrow Tissue" 111 : 1411-1420, 2003

14 Fox, J.G, "Laboratory Animal Medicine, 2nd ed." Academic Press 505-506, 2002

15 Inayat-Hussain, S.H, "Intrinsic pathway of hydroquinone induced apoptosis occurs via both caspasedependent and caspase-independent mechanisms" 18 (18): 420-427, 2005

16 Cronkite, E.P, "Hematotoxicity and carcinogenicity of inhaled benzene" 82 : 97-108, 1989

17 Aksoy, M, "Hematotoxicity and carcinogenicity of benzene. Environ" 82 : 193-197, 1989

18 Lee, E.W, "Effects of benzene on DNA strand breaks in vivo versus benzene metabolite-induced DNA strand breaks in vitro in mouse bone marrow cells" 108 : 497-508, 1991

19 Ibuki, Y, "Dysregulation of apoptosis by benzene metabolites and their relationships with carcinogenesis" 1690 (1690): 11-21, 2004

20 Zhao, Z.W, "Detection of apoptosis genes differentially expressed in patients with different degrees of benzene poisoning by cDNA microarray" 23 : 245-247, 2005

21 Wolman, S.R, "Cytologic and cytogenetic effects of benzene" 2 (2): 63-68, 1977

22 Yager, J.W, "Characterization of micronuclei induced in human lymphocytes by benzene metabolites" 50 : 393-399, 1990

23 Farris, G, "Benzene-induced hematotoxicity and bone marrow compensation in B6C3F1 mice" 36 : 119-129, 1997

24 Martinez-Velazquez, M, "Benzene metabolites induce apoptosis in lymphocytes" 58 : 65-70, 2006

25 Cronkite, E.P, "Benzene inhalation produces leukemia in mice" 75 : 358-361, 1984

26 Cronkite, E.P, "Benzene hematotoxicity and Leukemogenesis" 12 : 129-137, 1986

27 Runion, H. E, "Benzene exposure in the United States 1978-1983: An overview" 7 : 385-393, 1985

28 Aksoy, M, "Benzene and leukemia. Environ" 91 : 165-167, 1991

29 Snyder, R, "An overview of benzene metabolism. Environ" 194 : 1165-1171, 1996

30 Eastmond, D.A, "An interaction of benzene metabolites reproduces the myelotoxicity observed with benzene exposure" 91 : 85-95, 1987

31 Snyder, R, "A perspective on benzene leukemogenesis" 24 : 177-209, 1994

32 Kokel, D, "A class of benzenoid chemicals suppresses apoptosis in C" 7 (7): 2010-2015, 2006

33 Chen, H, ") Synergistic increase in chromosomal breakage within the euchromatin induced by an interaction of the benzene metabolites phenol and hydroquinone in mice" 16 : 1963-3969, 1995